Tobacco smoke is a very complex sample, containing upwards of 4800 individual substances (Hoffmann, Hoffmann et al. 2001, Baker, Bishop 2004, Thielena, Klusb et al. 2008). The volatility of these substances vanes over a large range as does the concentration. Some of the substances are additives to the tobacco, but most are products of pyrolysis/combustion of natural components of tobacco, e.g. cellulose. The relatively high temperature (~ 950 C) allows complex reactions to occur, generating a very diverse collection of compounds. However, almost two-thirds of additives undergo <5% decomposition or reaction (Baker, Bishop 2004). The compounds are distributed between the gas phase are particle phase (liquid aerosol). For organic compounds, about 75% are in the particle phase and 25% in the gas phase. Sampling the particles is a very challenging task. Typically particles are collected on filters, extracted (and sometimes derivatized), and then analyzed by GC/MS or LC/MS (Figure 1). It has been known for some time that artifacts can be produced in this procedure. We have confirmed this using the setup shown in Figure 1. Research in our lab has recently been focused on developing new approaches to reduce or eliminate collection/extraction steps in the analysis of smoke, to minimize artifact formation.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL120100-02
Application #
8737953
Study Section
Special Emphasis Panel (ZRG1)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
2
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Keating, James E; Minges, John T; Randell, Scott H et al. (2018) Paper Spray Mass Spectrometry for High-Throughput Quantification of Nicotine and Cotinine. Anal Methods 10:46-50
Reidel, Boris; Radicioni, Giorgia; Clapp, Phillip W et al. (2018) E-Cigarette Use Causes a Unique Innate Immune Response in the Lung, Involving Increased Neutrophilic Activation and Altered Mucin Secretion. Am J Respir Crit Care Med 197:492-501
Ghosh, Arunava; Coakley, Raymond C; Mascenik, Teresa et al. (2018) Chronic E-Cigarette Exposure Alters the Human Bronchial Epithelial Proteome. Am J Respir Crit Care Med 198:67-76
Rebuli, Meghan E; Speen, Adam M; Clapp, Phillip W et al. (2017) Novel applications for a noninvasive sampling method of the nasal mucosa. Am J Physiol Lung Cell Mol Physiol 312:L288-L296
Esther Jr, Charles R; Hill, David B; Button, Brian et al. (2017) Sialic acid-to-urea ratio as a measure of airway surface hydration. Am J Physiol Lung Cell Mol Physiol 312:L398-L404
Kesimer, Mehmet; Ford, Amina A; Ceppe, Agathe et al. (2017) Airway Mucin Concentration as a Marker of Chronic Bronchitis. N Engl J Med 377:911-922
Davis, Eric S; Sassano, M Flori; Goodell, Henry et al. (2017) E-Liquid Autofluorescence can be used as a Marker of Vaping Deposition and Third-Hand Vape Exposure. Sci Rep 7:7459
Clapp, Phillip W; Pawlak, Erica A; Lackey, Justin T et al. (2017) Flavored e-cigarette liquids and cinnamaldehyde impair respiratory innate immune cell function. Am J Physiol Lung Cell Mol Physiol 313:L278-L292
Clapp, Phillip W; Jaspers, Ilona (2017) Electronic Cigarettes: Their Constituents and Potential Links to Asthma. Curr Allergy Asthma Rep 17:79
Rowell, Temperance R; Reeber, Steven L; Lee, Shernita L et al. (2017) Flavored e-cigarette liquids reduce proliferation and viability in the CALU3 airway epithelial cell line. Am J Physiol Lung Cell Mol Physiol 313:L52-L66

Showing the most recent 10 out of 20 publications